Skip to main content

Table 1 Association of clinico-pathological characteristics of ER+/HER2- breast cancer patients with levels of ING1 in the stroma

From: Stromal ING1 expression induces a secretory phenotype and correlates with breast cancer patient survival

Characteristics

# of cases (%)

ER+/Her2-

Low lng1

High lng1

P-value

Age

    

   < 53

72 (16.25)

56

16

0.880

   ≥ 53

371 (83.75)

284

87

Menopausal status

    

  Pre-menopausal

26 (5.90)

17

9

 

  Peri-menopausal

21 (4.70)

18

3

0.231

  Post-menopausal

321 (72.50)

242

79

  n/a (male)

1 (0.20)

1

0

  Unknown

74 (16.70)

62

12

Stage

    

  I

188 (42.40)

148

40

0.365

  II

138 (31.20)

105

33

  III

36 (8.20)

24

12

  IV

5 (1.10)

3

2

  Unknown

76 (17.20)

60

16

Tumor grade

    

  1

103 (25.40)

88

15

0.001

  2

247 (60.80)

195

52

  3

56 (13.80)

31

25

Tumor size

    

   < 2 cm

223 (53.86)

179

44

0.020

   ≥ 2 cm

191 (46.14)

137

54

Lymph node status

    

  Negative

278 (72.77)

220

58

0.103

  Positive

104 (27.23)

74

30

Rx Tamoxifen

    

  No

161 (37.44)

118

43

0.196

  Yes

269 (62.56)

212

57

  1. The listed clinico-pathological characteristics were analyzed for their correlation with low/high levels of stromal ING1. Stromal ING1 shows a correlation with tumor grade and size in the ER+/ Her2- group of patients in the cohort
Back to article page

Molecular Cancer

ISSN: 1476-4598